Labgene Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
- Revenue Growth 29634.07%
- Profit Growth -22.65%
- Ebitda -9.00%
- Net Worth -602.11%
- Total Assets 22.06%
About Labgene Bio-Tech
Labgene Bio-Tech Private Limited (LBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 March 2019 (Five years and ten months 1 days old ). Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.50 Cr.
Maulikkumar Patel and Sachinkumar Patel serve as directors at the Company.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33110GJ2019PTC107358
- Company No.
107358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Labgene Bio-Tech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachinkumar Patel  | Director | 30-Mar-2019 | Current |
| Maulikkumar Patel | Director | 30-Mar-2019 | Current |
Financial Performance of Labgene Bio-Tech.
Labgene Bio-Tech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29634.07% increase. The company also saw a substantial fall in profitability, with a 22.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 602.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labgene Bio-Tech?
In 2023, Labgene Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2021 | Bank Of India | ₹3.50 Cr | Open |
How Many Employees Work at Labgene Bio-Tech?
Unlock and access historical data on people associated with Labgene Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labgene Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labgene Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
